Torrent Pharmaceuticals Ltd
NSE :TORNTPHARM BSE :500420 Sector : PharmaceuticalsBuy, Sell or Hold TORNTPHARM? Ask The Analyst
BSE
prev close
OPEN PRICE
bid price (qty)
offer price (qty)
volume
Today's low / high
52 WK low / high
NSE
prev close
open price
bid price (qty)
offer price (qty)
volume
Today's' low / high
52 WK low / high
19 Nov 3094.85 (-0.35%) | 18 Nov 3105.60 (0.10%) | 14 Nov 3102.40 (-0.46%) | 13 Nov 3116.60 (-1.09%) | 12 Nov 3151.05 (-0.02%) | 11 Nov 3151.65 (-1.51%) | 08 Nov 3199.85 (1.17%) | 07 Nov 3162.95 (-1.46%) | 06 Nov 3209.90 (0.81%) | 05 Nov 3184.15 (-0.51%) | 04 Nov 3200.55 (-0.15%) | 01 Nov 3205.30 (0.08%) | 31 Oct 3202.65 (2.07%) | 30 Oct 3137.80 (-2.42%) | 29 Oct 3215.65 (-3.05%) | 28 Oct 3316.70 (-3.38%) | 25 Oct 3432.85 (3.36%) | 24 Oct 3321.30 (0.07%) | 23 Oct 3318.95 (-0.62%) | 22 Oct 3339.65 (-1.56%) | 21 Oct 3392.50 (-1.65%) |
Price Chart Historical Data Technical Chart
Technical Analysis
Short Term Investors
Very Bearish
Medium Term Investors
Very Bearish
Long Term Investors
Bullish
Moving Averages
5 DMA
Bearish
3115.16
10 DMA
Bearish
3147.79
20 DMA
Bearish
3208.07
50 DMA
Bearish
3349.89
100 DMA
Bearish
3261.54
200 DMA
Bullish
2960.76
Intraday Support and Resistance
(Based on Pivot Points) |
Updated On Nov 19, 2024 04:00 PM For Next Trading Session
Pivots | Classic | Fibonacci | Camarilla | Woodie | DM |
---|---|---|---|---|---|
R3 | 3171.29 | 3152.42 | 3107.95 | - | - |
R2 | 3152.42 | 3134.22 | 3103.59 | 3149.94 | - |
R1 | 3123.64 | 3122.97 | 3099.22 | 3118.68 | 3138.03 |
P | 3104.77 | 3104.77 | 3104.77 | 3102.29 | 3111.96 |
S1 | 3075.99 | 3086.57 | 3090.48 | 3071.03 | 3090.38 |
S2 | 3057.12 | 3075.32 | 3086.11 | 3054.64 | - |
S3 | 3028.34 | 3057.12 | 3081.75 | - | - |
Key Metrics
EPS
48.34
P/E
64.02
P/B
13.92
Dividend Yield
0.9%
Market Cap
1,04,739 Cr.
Face Value
5
Book Value
222.39
ROE
25.38%
EBITDA Growth
922 Cr.
Debt/Equity
0.72
Shareholding History
Quarterly Result (Figures in Rs. Crores)
Torrent Pharmaceuticals Ltd Quaterly Results
Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | |
INCOME | 2686 | 2787 | 2776 | 2883 | 2873 |
PROFIT | 386 | 381.22 | 449 | 457 | 453 |
EPS | 11.39 | 13.1 | 13.27 | 13.51 | 13.37 |
Torrent Pharmaceuticals Ltd Quaterly Results
Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | |
INCOME | 2161 | 2112 | 2219 | 2459 | 2427 |
PROFIT | 327 | 297 | 410 | 469 | 460 |
EPS | 9.65 | 8.78 | 12.12 | 13.86 | 13.6 |
Profit & Loss (Figures in Rs. Crores)
Torrent Pharmaceuticals Ltd Profit & Loss
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
INCOME | 4999.87 | 7060.27 | 6178.72 | 6610.87 | 7646.41 | 8193.74 | 8340.72 | 8630.74 | 9499.1 | 11029.14 | |
PROFIT | 739.53 | 1834.37 | 879.74 | 636.59 | 595.93 | 1001.92 | 1239.71 | 1076.48 | 1217.5 | 1581.49 | |
EPS | 21.06 | 51.21 | 27.58 | 20.04 | 12.89 | 30.28 | 36.99 | 22.96 | 36.79 | 48.94 |
Torrent Pharmaceuticals Ltd Profit & Loss
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
INCOME | 3866.79 | 5782.98 | 4862 | 4809.09 | 6149.41 | 6462.2 | 6719.05 | 6964.83 | 7648.64 | 8692.87 | |
PROFIT | 612.66 | 1703.84 | 797.6 | 440.67 | 714.33 | 914.33 | 1125.1 | 984.59 | 1023.42 | 1342.2 | |
EPS | 17.29 | 47.3 | 25.24 | 14.24 | 22.03 | 27.73 | 33.62 | 29.29 | 31.06 | 40.1 |
Balance Sheet (Figures in Rs. Crores)
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 169.23 | 169.23 | 84.62 | 84.62 | 84.62 | 84.62 | 84.62 | 84.62 | 84.62 | 84.62 |
Reserves Total | 6,686.92 | 6,028.84 | 5,868.33 | 5,752.55 | 4,738.6 | 4,639.73 | 4,537.57 | 4,265.51 | 3,409.48 | 2,405.94 |
Total Shareholders Funds | 6,856.15 | 6,198.07 | 5,952.95 | 5,837.17 | 4,823.22 | 4,724.35 | 4,622.19 | 4,350.13 | 3,494.1 | 2,490.56 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0.52 | 0.49 | 0.46 | 0.43 |
Secured Loans | 3,149.71 | 4,530 | 3,295.03 | 4,331.79 | 5,179.69 | 5,548.24 | 5,663.03 | 2,496.38 | 2,338.45 | 2,719.12 |
Unsecured Loans | 872.23 | 838.56 | 774.62 | 542.34 | 604.66 | 489.86 | 799.29 | 13.75 | 13.23 | 21.23 |
Total Debt | 4,021.94 | 5,368.56 | 4,069.65 | 4,874.13 | 5,784.35 | 6,038.1 | 6,462.32 | 2,510.13 | 2,351.68 | 2,740.35 |
Other Liabilities | 454.89 | 415.39 | 378.2 | 382.59 | 457.14 | 310.83 | 306.84 | 270.97 | 256.01 | 215 |
Total Liabilities | 11,332.98 | 11,982.02 | 10,400.8 | 11,093.89 | 11,064.71 | 11,073.28 | 11,391.87 | 7,131.72 | 6,102.25 | 5,446.34 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 13,484.57 | 12,811.62 | 10,728.19 | 10,511.53 | 10,334.13 | 9,935.43 | 9,449.48 | 4,909.8 | 3,793.53 | 3,542.93 |
Less: Accumulated Depreciation | 5,346.46 | 4,690.17 | 4,305.54 | 3,446.9 | 2,801.01 | 2,187.72 | 1,594.8 | 1,221.36 | 934.45 | 710.27 |
Net Block | 8,138.11 | 8,121.45 | 6,422.65 | 7,064.63 | 7,533.12 | 7,747.71 | 7,854.68 | 3,688.44 | 2,859.08 | 2,832.66 |
Capital Work in Progress | 360.51 | 765.4 | 629.82 | 889.38 | 711.93 | 617.12 | 646.94 | 519.49 | 1,041.58 | 678.33 |
Investments | 172.84 | 198.79 | 226.31 | 181.14 | 2.11 | 353.44 | 492.36 | 803.64 | 779.68 | 297.65 |
Inventories | 2,279.07 | 2,229.64 | 2,462.32 | 2,681.2 | 2,148.22 | 1,935.15 | 1,966.3 | 1,559.15 | 1,357.98 | 1,067.17 |
Sundry Debtors | 1,844.3 | 1,943.82 | 1,632.48 | 1,523.37 | 1,649.34 | 1,435.71 | 1,253.45 | 950.89 | 1,445.09 | 1,587.26 |
Cash and Bank Balance | 839.04 | 571.46 | 403.41 | 603.5 | 666.65 | 816.04 | 867.23 | 893.72 | 647.03 | 567.36 |
Loans and Advances | 508.03 | 412.71 | 482.8 | 574.38 | 514.83 | 499.29 | 683.16 | 672.16 | 459.34 | 532.03 |
Total Current Assets | 5,470.44 | 5,157.63 | 4,981.01 | 5,382.45 | 4,979.04 | 4,686.19 | 4,770.14 | 4,075.92 | 3,909.44 | 3,753.82 |
Current Liabilities | 2,503.48 | 2,202.87 | 2,052.97 | 2,495.71 | 2,491.33 | 2,546.93 | 2,474.66 | 2,167.16 | 2,584.22 | 2,037.81 |
Provisions | 568.07 | 425.02 | 452.51 | 485.05 | 453.7 | 493.21 | 376.65 | 301.8 | 199.66 | 230.81 |
Total Current Liabilities & Provisions | 3,071.55 | 2,627.89 | 2,505.48 | 2,980.76 | 2,945.03 | 3,040.14 | 2,851.31 | 2,468.96 | 2,783.88 | 2,268.62 |
Net Current Assets | 2,398.89 | 2,529.74 | 2,475.53 | 2,401.69 | 2,034.01 | 1,646.05 | 1,918.83 | 1,606.96 | 1,125.56 | 1,485.2 |
Deferred Tax Assets | 2,013 | 1,974.35 | 1,400.02 | 1,383.07 | 1,294.84 | 1,189.75 | 275.92 | 309.88 | 516.75 | 84.14 |
Deferred Tax Liability | 2,113.92 | 1,832.62 | 1,099.93 | 961.41 | 861.63 | 827.4 | 0.04 | 101.41 | 405.31 | 188.84 |
Net Deferred Tax | -100.92 | 141.73 | 300.09 | 421.66 | 433.21 | 362.35 | 275.88 | 208.47 | 111.44 | -104.7 |
Other Assets | 363.55 | 224.91 | 346.4 | 135.39 | 350.33 | 346.61 | 203.18 | 304.72 | 184.91 | 257.2 |
Total Assets | 11,332.98 | 11,982.02 | 10,400.8 | 11,093.89 | 11,064.71 | 11,073.28 | 11,391.87 | 7,131.72 | 6,102.25 | 5,446.34 |
Contingent Liabilities | 157.44 | 150.83 | 128.74 | 122.89 | 129.82 | 125.7 | 122.55 | 109.17 | 95.42 | 33.68 |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 169.23 | 169.23 | 84.62 | 84.62 | 84.62 | 84.62 | 84.62 | 84.62 | 84.62 | 84.62 |
Reserves Total | 6,659.53 | 6,286.73 | 6,260.8 | 5,945.48 | 5,036.35 | 4,930.65 | 4,471.87 | 4,369.09 | 3,622.69 | 2,620.97 |
Total Shareholders Funds | 6,828.76 | 6,455.96 | 6,345.42 | 6,030.1 | 5,120.97 | 5,015.27 | 4,556.49 | 4,453.71 | 3,707.31 | 2,705.59 |
Secured Loans | 2,982.96 | 4,365.56 | 3,143.41 | 4,184.78 | 4,991.22 | 5,340.72 | 5,045.27 | 2,431.88 | 2,236.15 | 2,500.05 |
Unsecured Loans | 361.24 | 209.91 | 204.1 | 219.36 | 303.12 | 282.35 | 799.29 | 13.75 | 13.23 | 21.23 |
Total Debt | 3,344.2 | 4,575.47 | 3,347.51 | 4,404.14 | 5,294.34 | 5,623.07 | 5,844.56 | 2,445.63 | 2,249.38 | 2,521.28 |
Other Liabilities | 292.35 | 266.87 | 217.83 | 200.49 | 251.57 | 176.68 | 164.57 | 133.22 | 123.71 | 104.06 |
Total Liabilities | 10,465.31 | 11,298.3 | 9,910.76 | 10,634.73 | 10,666.88 | 10,815.02 | 10,565.62 | 7,032.56 | 6,080.4 | 5,330.93 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 12,999.81 | 12,366.86 | 10,002.35 | 9,952.74 | 9,805.61 | 9,568.39 | 8,905.1 | 4,634.19 | 3,531.56 | 3,416.05 |
Less : Accumulated Depreciation | 5,013.89 | 4,395.01 | 3,751.1 | 3,211.5 | 2,608.11 | 2,143.24 | 1,476.57 | 1,110.7 | 850.17 | 652.55 |
Net Block | 7,985.92 | 7,971.85 | 6,251.25 | 6,741.24 | 7,197.5 | 7,425.15 | 7,428.53 | 3,523.49 | 2,681.39 | 2,763.5 |
Capital Work in Progress | 226.23 | 697.93 | 567.5 | 588.11 | 536.41 | 497.58 | 447.38 | 473.07 | 983.69 | 627.78 |
Investments | 463.31 | 361.21 | 367.64 | 313.92 | 134.89 | 486.22 | 625.05 | 935.84 | 918.15 | 433.83 |
Inventories | 1,565.59 | 1,602.23 | 1,797.11 | 1,911.74 | 1,507.76 | 1,358.3 | 1,299.4 | 1,032.29 | 970.13 | 781.15 |
Sundry Debtors | 1,571.94 | 1,729.44 | 1,541.35 | 1,544.26 | 1,508.94 | 1,356.01 | 1,108.04 | 1,018.47 | 911.5 | 1,181.32 |
Cash and Bank Balance | 108.76 | 147.61 | 69.46 | 66.42 | 390.95 | 237.84 | 57.09 | 78.22 | 82.37 | 69.68 |
Loans and Advances | 353.73 | 291.71 | 468.15 | 480.41 | 411.59 | 445.45 | 699.39 | 629.17 | 409.56 | 403.32 |
Total Current Assets | 3,600.02 | 3,770.99 | 3,876.07 | 4,002.83 | 3,819.24 | 3,397.6 | 3,163.92 | 2,758.15 | 2,373.56 | 2,435.47 |
Current Liabilities | 1,054.53 | 1,021.7 | 927.9 | 1,019.48 | 1,123.82 | 1,120.67 | 1,174.39 | 862.22 | 989.89 | 807.88 |
Provisions | 200.94 | 150.63 | 120.34 | 106.83 | 93.77 | 84.07 | 80.06 | 55.4 | 46.95 | 169.26 |
Total Current Liabilities & Provisions | 1,255.47 | 1,172.33 | 1,048.24 | 1,126.31 | 1,217.59 | 1,204.74 | 1,254.45 | 917.62 | 1,036.84 | 977.14 |
Net Current Assets | 2,344.55 | 2,598.66 | 2,827.83 | 2,876.52 | 2,601.65 | 2,192.86 | 1,909.47 | 1,840.53 | 1,336.72 | 1,458.33 |
Deferred Tax Assets | 405.38 | 612.85 | 796.86 | 1,026.91 | 1,003.33 | 848.97 | 0.82 | 0 | 117.89 | 31.83 |
Deferred Tax Liability | 1,061.19 | 1,014.15 | 990.42 | 998.58 | 935.57 | 856.48 | 0 | 100.73 | 289.19 | 220.67 |
Net Deferred Tax | -655.81 | -401.3 | -193.56 | 28.33 | 67.76 | -7.51 | 0.82 | -100.73 | -171.3 | -188.84 |
Other Assets | 101.11 | 69.95 | 90.1 | 86.61 | 128.67 | 220.72 | 154.37 | 360.36 | 331.75 | 236.33 |
Total Assets | 10,465.31 | 11,298.3 | 9,910.76 | 10,634.73 | 10,666.88 | 10,815.02 | 10,565.62 | 7,032.56 | 6,080.4 | 5,330.93 |
Contingent Liabilities | 1,036.07 | 1,017.36 | 928.05 | 126.18 | 132.56 | 128.58 | 125.48 | 112.09 | 98.41 | 562.25 |
Cash Flow (Figures in Rs. Crores)
Net Profit before Tax and Extr... | 2,352.11 |
Depreciation | 808.27 |
Interest (Net) | 342.08 |
P/L on Sales of Assets | 0.02 |
P/L on Sales of Invest | -17.99 |
Prov. and W/O (Net) | 7.08 |
P/L in Forex | -57.09 |
Total Adjustments (PBT and Ext... | 993.99 |
Operating Profit before Workin... | 3,346.1 |
Trade and 0ther Receivables | 78.32 |
Inventories | -49.43 |
Trade Payables | 413.55 |
Loans and Advances | -6.78 |
Total Adjustments (OP before W... | 418.08 |
Cash Generated from/(used in) ... | 3,764.18 |
Direct Taxes Paid | -498.1 |
Total Adjustments(Cash Generat... | -498.1 |
Cash Flow before Extraordinary... | 3,266.08 |
Net Cash from Operating Activi... | 3,266.08 |
Purchased of Fixed Assets | -432.78 |
Sale of Fixed Assets | 133.66 |
Sale of Investments | 33.09 |
Interest Received | 13.12 |
Net Cash used in Investing Act... | -159.83 |
Of the Long Tem Borrowings | -1,236.01 |
Of the Short Term Borrowings | -133.43 |
Of Financial Liabilities | -23.9 |
Dividend Paid | -1,015.34 |
Interest Paid | -370.96 |
Net Cash used in Financing Act... | -2,779.64 |
Net Profit before Tax and Extr... | 1,916.57 |
Depreciation | 761.05 |
Interest (Net) | 300.5 |
Dividend Received | 50.2 |
P/L on Sales of Assets | -3.03 |
P/L on Sales of Invest | -17.99 |
Prov. and W/O (Net) | 3.92 |
P/L in Forex | -36.64 |
Total Adjustments (PBT and Ext... | 957.61 |
Operating Profit before Workin... | 2,874.18 |
Trade and 0ther Receivables | 139.49 |
Inventories | 36.64 |
Trade Payables | 152.17 |
Loans and Advances | 36.55 |
Total Adjustments (OP before W... | 343.6 |
Cash Generated from/(used in) ... | 3,217.78 |
Direct Taxes Paid | -324.68 |
Total Adjustments(Cash Generat... | -324.68 |
Cash Flow before Extraordinary... | 2,893.1 |
Net Cash from Operating Activi... | 2,893.1 |
Purchased of Fixed Assets | -344.34 |
Sale of Fixed Assets | 31.49 |
Sale of Investments | 33.04 |
Interest Received | 4.18 |
Invest.In Subsidiaires | -128.05 |
Net Cash used in Investing Act... | -296.07 |
Proceed from Short Tem Borrowi... | 2.23 |
Of the Long Tem Borrowings | -1,236.01 |
Of Financial Liabilities | -5.15 |
Dividend Paid | -1,015.34 |
Interest Paid | -323.3 |
Net Cash used in Financing Act... | -2,577.57 |
Company Details
Registered Office |
|
Address | Torrent House, Off Ashram Road |
City | Ahmedabad |
State | Gujarat |
Pin Code | 380009 |
Tel. No. | 91-79-26599000 |
Fax. No. | 91-79-26582100 |
investorservices@torrentpharma.com | |
Internet | http://www.torrentpharma.com |
Registrars |
|
Address | Torrent House |
City | Ahmedabad |
State | Gujarat |
Pin Code | 380009 |
Tel. No. | 91-79-26599000 |
Fax. No. | 91-79-26582100 |
investorservices@torrentpharma.com | |
Internet | http://www.torrentpharma.com |
Management |
|
Name | Designation |
Sudhir Mehta | Chairman Emeritus |
Samir Mehta | Executive Chairman |
Ameera Shah | Independent Director |
Nayantara Bali | Independent Director |
Jinesh Shah | Director (Operation) |
Maurice Chagnaud | Independent Director |
Aman Mehta | Whole Time Director |
Manish Choksi | Independent Director |
Chintan Trivedi | Company Sec. & Compli. Officer |
Nikhil Khattau | Independent Director |
Jindal Mehta | Non Executive Director |